Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Rosetta Genomics Ltd. (ROSGQ) had Debt to Equity Ratio of 0.03 for the most recently reported fiscal year, ending 2016-12-31.
| Income Statement Financials | |
$9.23M |
|
$-16.23M |
|
$7.44M |
|
$1.79M |
|
$24.90M |
|
$-15.66M |
|
$-0.60M |
|
$-16.27M |
|
$-16.27M |
|
$-16.23M |
|
$-16.23M |
|
$-16.23M |
|
$-16.23M |
|
$-15.66M |
|
$-14.76M |
|
1.74M |
|
1.74M |
|
$-9.31 |
|
$-9.31 |
|
| Balance Sheet Financials | |
$9.51M |
|
$2.44M |
|
$2.45M |
|
$11.96M |
|
$3.80M |
|
$0.07M |
|
$3.74M |
|
$7.54M |
|
$4.42M |
|
$4.42M |
|
$4.42M |
|
1.84M |
|
| Cash Flow Statement Financials | |
$-10.37M |
|
$0.82M |
|
$3.26M |
|
$12.45M |
|
$6.16M |
|
$-6.28M |
|
$0.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.50 |
|
-- |
|
-- |
|
0.01 |
|
|
Debt to Equity Ratio |
0.03 |
19.44% |
|
-169.63% |
|
-169.63% |
|
-159.84% |
|
-176.16% |
|
-175.80% |
|
$-10.59M |
|
-- |
|
-- |
|
-- |
|
0.77 |
|
-- |
|
2.87 |
|
127.28 |
|
-367.51% |
|
-367.51% |
|
-135.72% |
|
-362.18% |
|
$2.40 |
|
$-6.08 |
|
$-5.95 |
|